• 1
    Ellman M, Hurwitz H, Thomas C, Kozloff M: Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18: 17411743, 1991
  • 2
    Cobeta-Garcia J, Ruiz-Jimeno M, Fontova-Garrofe R: Non-Hodgkin's lymphoma, rheumatoid arthritis and methotrexate. J Rheumatol 20: 200201, 1993
  • 3
    Liote F, Pertuiset E, Cochand-Priollet B, D'Agay M-F, Dombret H, Numeric P, D'Anglejan G, Kuntz D: Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis: role of Epstein-Barr virus infection. J Rheumatol 22: 11741178, 1995
  • 4
    Kingsmore S, Hall B, Allen N, Rice J, Caldwell D: Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review. J Rheumatol 19: 14621465, 1992
  • 5
    Moms C, Moms A: Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate. J Rheumatol 20: 21722173, 1993
  • 6
    Taillan B, Ganier G, Ferrari E, Castanet J, Pesce A, Fuzibet J, Dujardin P: Malignant lymphoma in a patient with rheumatoid arthritis treated with low-dose methotrexate. Rev Rhum 60: 214216, 1993
  • 7
    Kamel O, Van de Rijn M, Weiss L, Del Zoppo G, Hench P, Robbins B, Montgomery P, Warnke R, Dorfman R: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328: 13171321, 1993
  • 8
    Shiroky J, Frost A, Skelton J, Haegert D, Newkirk M, Neville C: Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 18: 11721175, 1991
  • 9
    Weiss L, Movahed L: In situ demonstration of Epstein-Barr genomes in viral-associated B-cell lymphoproliferations. Am J Pathol 134: 651659, 1989
  • 10
    Reed T, Reid A, Wallberg K, O'Leary T, Frizera G: Determination of B-cell clonality in paraffin-embedded lymph nodes using the polymerase chain reaction. Diagn Mol Pathol 2: 1424, 1993
  • 11
    Wan J, Trainor K, Briscom M, Morey A: Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 43: 888890, 1990
  • 12
    Prior P: Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 78: 1521, 1985
  • 13
    Gridley G, Klippel J, Hoover R, Fraumeni J: Incidence of cancer among men with the Felty syndrome. Ann Intern Med 120: 3539, 1994
  • 14
    Kamel O, van de Rijn M, LeBrun D, Weiss L, Warnke R, Dorfman R: Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25: 638643, 1994
  • 15
    Tosato G, Steinberg A, Yarchoan R, Heilman C, Pike S, De Seau V, Blaese R: Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 73: 17891795, 1984
  • 16
    Depper J, Bluestein H, Zvaifler N: Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol 127: 18991902, 1981
  • 17
    Nalesnik M, Makowka L, Starzl T: The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 25: 365472, 1988
  • 18
    Ho M, Miller G, Atchison R, Breinig M, Dummer J, Andiman W, Starzl T, Eastman R, Griffith B, Hardesty R, Bahnson H, Hakala T, Rosenthal J: Epstein-Barr virus infection and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 152: 876886, 1985
  • 19
    Morrison V, Dunn D, Manivel J, Gajl-Peczalska K, Peterson B: Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 97: 1424, 1994
  • 20
    Hanto D, Gajl-Peczalska K, Frizzera G, Arthur D, Balfour H, McClain K, Simmons R, Najarian J: Epstein-Barr virus induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg 198: 356369, 1983
  • 21
    Hanto D, Frizzera G, Gajl-Peczalska KJ, Balfour H, Simmons R, Najarian J: Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative diseases. Transplant Proc 17: 8992, 1985